Discovery of Novel and Potent Leukotriene B4 Receptor Antagonists. Part 1

Author:

Goodnow Robert A.1,Hicks Alexandra2,Sidduri Achyutharao1,Kowalczyk Agnieszka1,Dominique Romyr1,Qiao Qi1,Lou Jian Ping1,Gillespie Paul1,Fotouhi Nader1,Tilley Jefferson1,Cohen Noal1,Choudhry Satish3,Cavallo Gary2,Tannu Shahid A.2,Ventre Jessica D.2,Lavelle Danielle2,Tare Nadine S.2,Oh Hyesun4,Lamb Martin4,Kurylko Grazyna5,Hamid Rachid5,Wright Matthew B.5,Pamidimukkala Anjula4,Egan Thomas4,Gubler Ueli5,Hoffman Ann F.5,Wei Xin6,Li Ying L.6,O’Neil John7,Marcano Ruben7,Pozzani Karen7,Molinaro Tina7,Santiago Jennifer7,Singer Laura7,Hargaden Maureen7,Moore David4,Catala A. Robert4,Chao Lisa C. F.8,Hermann Gesine9,Venkat Radhika10,Mancebo Helena10,Renzetti Louis M.2

Affiliation:

1. Departments of Discovery Chemistry

2. RNA Therapeutics

3. Chemical Synthesis

4. Non-Clinical Safety

5. Discovery Technologies

6. In Silico Sciences

7. Laboratory Animal Resources

8. PDR Lifecycle Management

9. ChemOvation Ltd., Graylands, Langhurst Wood Road, Horsham, West Sussex RH12 4QD, U.K.

10. Multispan Inc, 26219 Eden Landing Road, Hayward, California 94545

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3